Bausch Health
BHC
#4718
Rank
โ‚น178.26 B
Marketcap
โ‚น480.17
Share price
3.38%
Change (1 day)
-21.55%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น89.57. In 2024 the company made an earnings per share (EPS) of -โ‚น11.08 an increase over its 2023 EPS that were of -โ‚น149.59.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-864.38%
2024-โ‚น11.08-92.59%
2023-โ‚น149.59160.89%
2022-โ‚น57.34-76.64%
2021-โ‚น245.4468.45%
2020-โ‚น145.70-68.91%
2019-โ‚น468.63-57.11%
2018-โ‚น1,093-272.22%
2017โ‚น634.49-199.29%
2016-โ‚น639.00798.7%
2015-โ‚น71.10-128.31%
2014โ‚น251.17-204.62%
2013-โ‚น240.09602.7%
2012-โ‚น34.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น22.16-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น87.72-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA